Company profile
Oncospace, Inc.
Oncospace, Inc. has 3 AI-enabled medical devices on the FDA list. The first decision was on March 12, 2021 and the most recent on April 11, 2025 (Oncospace). Its most common review panel is Radiology (3 devices).
3AI devices
2021First decision
2025Latest decision
1Specialties
Per year
202120232025